UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 775

Sortiert nach

Androgen-regulated miR-32 targets BTG2 and is overexpressed in castration-resistant prostate cancer

Oncogene, 2012-10, Vol.31 (41), p.4460-4471

2012

Volltextzugriff (PDF)

Prostate cancer prognosis after initiation of androgen deprivation therapy among statin users. A population-based cohort study

Prostate cancer and prostatic diseases, 2021-09, Vol.24 (3), p.917-924

2021

Volltextzugriff (PDF)

Statin use and outcomes of oncological treatment for castration-resistant prostate cancer

Scientific reports, 2023-11, Vol.13 (1), p.18866-18866, Article 18866

2023

Volltextzugriff (PDF)

Overexpression of androgen receptor enhances the binding of the receptor to the chromatin in prostate cancer

Oncogene, 2012-04, Vol.31 (17), p.2153-2163

2012

Volltextzugriff (PDF)

Outcomes of prostate cancer screening among men using antidiabetic medication

Scientific reports, 2021-04, Vol.11 (1), p.7363-7363, Article 7363

2021

Volltextzugriff (PDF)

Single-cell ATAC and RNA sequencing reveal pre-existing and persistent cells associated with prostate cancer relapse

Nature communications, 2021-09, Vol.12 (1), p.5307-5307, Article 5307

2021

Volltextzugriff (PDF)

Prostate cancer risk and nonsteroidal antiinflammatory drug use in the Finnish prostate cancer screening trial

British journal of cancer, 2014-09, Vol.111 (7), p.1421-1431

2014

Volltextzugriff (PDF)

Integrative proteomics in prostate cancer uncovers robustness against genomic and transcriptomic aberrations during disease progression

Nature communications, 2018-03, Vol.9 (1), p.1176-13, Article 1176

2018

Volltextzugriff (PDF)

Cost-effectiveness of prostate cancer screening: a simulation study based on ERSPC data

JNCI : Journal of the National Cancer Institute, 2015-01, Vol.107 (1), p.366-366

2015

Volltextzugriff (PDF)

Prostate cancer risk among users of digoxin and other antiarrhythmic drugs in the Finnish Prostate Cancer Screening Trial

Cancer causes & control, 2016-02, Vol.27 (2), p.157-164

2016

Volltextzugriff (PDF)

Tumor features and survival after radical prostatectomy among antidiabetic drug users

Prostate cancer and prostatic diseases, 2016-12, Vol.19 (4), p.367-373

2016

Volltextzugriff (PDF)

Prostate cancer incidence among finasteride and alpha-blocker users in the Finnish Prostate Cancer Screening Trial

British journal of cancer, 2009-09, Vol.101 (5), p.843-848

2009

Volltextzugriff (PDF)

Cardiovascular drug use and the incidence of erectile dysfunction

International journal of impotence research, 2007-03, Vol.19 (2), p.208-212

2007

Volltextzugriff (PDF)

Germline variants in IL4, MGMT and AKT1 are associated with prostate cancer-specific mortality: An analysis of 12,082 prostate cancer cases

Prostate cancer and prostatic diseases, 2018-06, Vol.21 (2), p.228-237

2018

Volltextzugriff (PDF)

Effect of life-style factors on incidence of erectile dysfunction

International journal of impotence research, 2004-10, Vol.16 (5), p.389-394

2004

Volltextzugriff (PDF)

Responder analysis of the effects of denosumab on bone mineral density in men receiving androgen deprivation therapy for prostate cancer

Prostate cancer and prostatic diseases, 2012-09, Vol.15 (3), p.308-312

2012

Volltextzugriff (PDF)

Anticoagulants and cancer mortality in the Finnish randomized study of screening for prostate cancer

Cancer causes & control, 2019-08, Vol.30 (8), p.877-888

2019

Volltextzugriff (PDF)

Identification of germline MLH1 alterations in familial prostate cancer

European journal of cancer (1990), 2006-11, Vol.42 (16), p.2802-2806

2006

Volltextzugriff (PDF)

Erectile dysfunction influences the subsequent incidence of lower urinary tract symptoms and bother

International journal of impotence research, 2007-06, Vol.19 (3), p.317-320

2007

Volltextzugriff (PDF)

Urodynamic findings in primary progressive multiple sclerosis are associated with increased volumes of plaques and atrophy in the central nervous system

Acta neurologica Scandinavica, 2004-02, Vol.109 (2), p.100-105

2004

Volltextzugriff (PDF)

Specificity of serum prostate-specific antigen determination in the Finnish prostate cancer screening trial

British journal of cancer, 2007-01, Vol.96 (1), p.56-60

2007

Volltextzugriff (PDF)

Oxidative/nitrosative stress and peroxiredoxin 2 are associated with grade and prognosis of human renal carcinoma

APMIS : acta pathologica, microbiologica et immunologica Scandinavica, 2006-05, Vol.114 (5), p.329-337

2006

Volltextzugriff (PDF)

Association between PSA kinetics and cancer-specific mortality in patients with localised prostate cancer: analysis of the placebo arm of the SPCG-6 study

Annals of oncology, 2016-03, Vol.27 (3), p.460-466

2016

Volltextzugriff (PDF)

A missense substitution A49T in the steroid 5-alpha-reductase gene ( ) is not associated with prostate cancer in Finland

British journal of cancer, 2001-05, Vol.84 (10), p.1344-1347

2001

Volltextzugriff (PDF)

Concomitant i.v. and oral clodronate in the relief of bone pain - a double-blind placebo-controlled study in patients with prostate cancer

British journal of cancer, 1997-01, Vol.76 (7), p.939-942

1997

Volltextzugriff (PDF)

1 – 25 von 775

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(688)
Mit Volltextzugriff
(616)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(572)
Life Sciences & Biomedicine
(546)
Humans
(514)
Male
(485)
Middle Aged
(319)
Aged
(313)
Biological And Medical Sciences
(302)
Medical Sciences
(297)
Urology & Nephrology
(272)
Prostate Cancer
(204)
Nephrology. Urinary Tract Diseases
(196)
Urinary Tract. Prostate Gland
(177)
Oncology
(168)
Tumors Of The Urinary System
(144)
Tumors
(127)
Aged, 80 And Over
(115)
Urology
(114)
Prostatic Neoplasms - Genetics
(110)
Adult
(109)
Finland - Epidemiology
(104)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Androgen-regulated miR-32 targets BTG2 and is overexpressed in castration-resistant prostate cancer

Prostate cancer prognosis after initiation of androgen deprivation therapy among statin users. A population-based cohort study

Statin use and outcomes of oncological treatment for castration-resistant prostate cancer

Overexpression of androgen receptor enhances the binding of the receptor to the chromatin in prostate cancer

Outcomes of prostate cancer screening among men using antidiabetic medication

Single-cell ATAC and RNA sequencing reveal pre-existing and persistent cells associated with prostate cancer relapse

Prostate cancer risk and nonsteroidal antiinflammatory drug use in the Finnish prostate cancer screening trial

Integrative proteomics in prostate cancer uncovers robustness against genomic and transcriptomic aberrations during disease progression

Cost-effectiveness of prostate cancer screening: a simulation study based on ERSPC data

Prostate cancer risk among users of digoxin and other antiarrhythmic drugs in the Finnish Prostate Cancer Screening Trial

Tumor features and survival after radical prostatectomy among antidiabetic drug users

Prostate cancer incidence among finasteride and alpha-blocker users in the Finnish Prostate Cancer Screening Trial

Cardiovascular drug use and the incidence of erectile dysfunction

Germline variants in IL4, MGMT and AKT1 are associated with prostate cancer-specific mortality: An analysis of 12,082 prostate cancer cases

Effect of life-style factors on incidence of erectile dysfunction

Responder analysis of the effects of denosumab on bone mineral density in men receiving androgen deprivation therapy for prostate cancer

Anticoagulants and cancer mortality in the Finnish randomized study of screening for prostate cancer

Identification of germline MLH1 alterations in familial prostate cancer

Erectile dysfunction influences the subsequent incidence of lower urinary tract symptoms and bother

Urodynamic findings in primary progressive multiple sclerosis are associated with increased volumes of plaques and atrophy in the central nervous system

Specificity of serum prostate-specific antigen determination in the Finnish prostate cancer screening trial

Oxidative/nitrosative stress and peroxiredoxin 2 are associated with grade and prognosis of human renal carcinoma

Association between PSA kinetics and cancer-specific mortality in patients with localised prostate cancer: analysis of the placebo arm of the SPCG-6 study

A missense substitution A49T in the steroid 5-alpha-reductase gene ( ) is not associated with prostate cancer in Finland

Concomitant i.v. and oral clodronate in the relief of bone pain - a double-blind placebo-controlled study in patients with prostate cancer

Suchergebnisse filtern